Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
In a new study, researchers report the use of inhaled corticosteroids (HFNC) in patients with mild to moderate bronchiolitis...
Read Full NewsThe U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet to treat infestations caused by the New World screwworm...
Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.
A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.
A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.
Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.
Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...
Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World Health Organization said, as the outbreak of the dangerous...
1.
Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.
2.
Decrease seen in in situ breast cancer since 2009
3.
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain
4.
Bayer is transforming pharmaceutical research into women's health
5.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
1.
Comprehensive Standards in Oncology for Modern Medicine
2.
Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies
3.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
4.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
5.
Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge